Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Value of routine ‘day 14’ marrow exam in newly diagnosed AML

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. O’Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA et al. Acute myeloid leukemia, version 2. J Natl Compr Canc Netw 2013; 11: 1047–1055.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mattison R, Luger S, Lazarus H . New strategies for the evaluation of the nadir bone marrow following induction in acute myeloid leukemia. Curr Opin Hematol 2013; 20: 93–99.

    Article  CAS  PubMed  Google Scholar 

  3. Hussein K, Jahagirdar B, Gupta P, Burns L, Larsen K, Weisdorf D . Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia. Am J Hematol 2008; 83: 446–450.

    Article  PubMed  Google Scholar 

  4. Morris TA, DeCastro CM, Diehl LF, Gockerman JP, Lagoo AS, Li Z et al. Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia. Leuk Res 2013; 37: 28–31.

    Article  PubMed  Google Scholar 

  5. Yanada M, Borthakur G, Ravandi F, Bueso-Ramos C, Kantarjian H, Estey E . Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia. Haematologica 2008; 93: 1263–1265.

    Article  PubMed  Google Scholar 

  6. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Group study. Blood 2000; 96: 4075–4083.

    CAS  PubMed  Google Scholar 

  7. Othus M, Sudipto M, Sekeres M, Godwin J, Anderson J, Petersdorf S et al. Prediction of CR on reinduction in patients with newly diagnosed acute myeloid leukemia given intensive induction regimens; a report from SWOG and Cleveland Clinic. Blood 2013 122: 3924 (ASH Abstract 2013).

  8. Vainstein V, Buckley SA, Shukron O, Estey EH, Abkowitz JL, Wood BL et al. Rapid rate of peripheral blood blast clearance accurately predicts complete remission in acute myeloid leukemia. Leukemia 2014; 28: 713–716.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E Estey.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yezefski, T., Xie, H., Walter, R. et al. Value of routine ‘day 14’ marrow exam in newly diagnosed AML. Leukemia 29, 247–249 (2015). https://doi.org/10.1038/leu.2014.268

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2014.268

This article is cited by

Search

Quick links